Sleep disorders in patients with Parkinson's disease: Epidemiology and management

CNS Drugs

Volumn 15, Issue 4, 2001, Pages 267-275

  Larsen, Jan P ^a   Tandberg, Elise ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; MIANSERIN; NEUROLEPTIC AGENT; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; ZOLPIDEM; ZOPICLONE;

DEPRESSION; HUMAN; INSOMNIA; PARASOMNIA; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; REM SLEEP DEPRIVATION; REVIEW; RISK FACTOR; SLEEP DISORDER; SOMNOLENCE;

EID: 0035054370     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200115040-00002     Document Type: Review

References (2)

1. Tandberg E, Larsen JP, Nessler EG, et al. The epidemiology of Parkinson's disease in the county of Rogaland, Norway. Mov Disord 1995; 5: 541-9
2. Mutch WJ, Dingwall-Fordyce I, Downie AW, et al. Parkinson's disease in a Scottish city. BMJ 1986; 292: 534-6